Literature DB >> 28913657

Radical cystectomy for recurrent urothelial carcinoma after prior partial cystectomy: perioperative and oncologic outcomes.

Ross J Mason1, Igor Frank1, Bimal Bhindi1, Matthew K Tollefson1, R Houston Thompson1, R Jeffrey Karnes1, Robert Tarrell2, Prabin Thapa2, Stephen A Boorjian3.   

Abstract

PURPOSE: To evaluate perioperative and oncologic outcomes of patients undergoing radical cystectomy (RC) for recurrence of urothelial carcinoma (UC) after prior partial cystectomy (PC), and to compare these outcomes to patients undergoing primary RC.
METHODS: Patients who underwent RC for recurrence of UC after prior PC were matched 1:3 to patients undergoing primary RC based on age, pathologic stage, and decade of surgery. Perioperative and oncologic outcomes were compared using Wilcoxon sign-rank test, McNemars test, the Kaplan-Meier method, and Cox proportional hazards regression analyses.
RESULTS: Overall, the cohorts were well matched on clinical and pathological characteristics. No difference was noted in operative time (median 322 versus 303 min; p = 0.41), estimated blood loss (median 800 versus 700 cc, p = 0.10) or length of stay (median 9 versus 10 days; p = 0.09). Similarly, there were no differences in minor (51.7 versus 44.3%; p = 0.32) or major (10.3 versus 12.6%; p = 0.66) perioperative complications. Median follow-up after RC was 5.0 years (IQR 1.5, 13.1 years). Notably, CSS was significantly worse for patients who underwent RC after PC (10 year-46.8 versus 65.9%; p = 0.03). On multivariable analysis, prior PC remained independently associated with an increased risk of bladder cancer death (HR 2.28; 95% CI 1.17, 4.42).
CONCLUSIONS: RC after PC is feasible, without significantly adverse perioperative outcomes compared to patients undergoing primary RC. However, the risk of death from bladder cancer may be higher, suggesting the need for careful patient counseling prior to PC and the consideration of such patients for adjuvant therapy after RC.

Entities:  

Keywords:  Outcomes; Partial cystectomy; Radical cystectomy; Survival; Urothelial carcinoma

Mesh:

Year:  2017        PMID: 28913657     DOI: 10.1007/s00345-017-2087-4

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  20 in total

1.  Treatment of muscle invasive bladder cancer: evidence from the National Cancer Database, 2003 to 2007.

Authors:  Ugo Fedeli; Stacey A Fedewa; Elizabeth M Ward
Journal:  J Urol       Date:  2010-11-12       Impact factor: 7.450

2.  Segmental resection for carcinoma of the bladder: review of 102 patients.

Authors:  M I Resnick; V J O'Conor
Journal:  J Urol       Date:  1973-06       Impact factor: 7.450

3.  Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.

Authors:  Wassim Kassouf; David Swanson; Ashish M Kamat; Dan Leibovici; Arlene Siefker-Radtke; Mark F Munsell; H Barton Grossman; Colin P N Dinney
Journal:  J Urol       Date:  2006-06       Impact factor: 7.450

4.  Carcinoma of the bladder treated by segmental resection.

Authors:  T W Schoborg; J L Sapolsky; C W Lewis
Journal:  J Urol       Date:  1979-10       Impact factor: 7.450

5.  Partial cystectomy in the treatment of primary and secondary carcinoma of the bladder.

Authors:  A C Novick; B H Stewart
Journal:  J Urol       Date:  1976-11       Impact factor: 7.450

6.  Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.

Authors:  Jeffrey M Holzbeierlein; Ernesto Lopez-Corona; Bernard H Bochner; Harry W Herr; S Machele Donat; Paul Russo; Guido Dalbagni; Pramod C Sogani
Journal:  J Urol       Date:  2004-09       Impact factor: 7.450

7.  Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base.

Authors:  Phillip J Gray; Stacey A Fedewa; William U Shipley; Jason A Efstathiou; Chun Chieh Lin; Anthony L Zietman; Katherine S Virgo
Journal:  Eur Urol       Date:  2012-11-19       Impact factor: 20.096

8.  Practice patterns and recurrence after partial cystectomy for bladder cancer.

Authors:  Nader Fahmy; Armen Aprikian; Simon Tanguay; Salaheddin M Mahmud; Mohammed Al-Otaibi; Suganthiny Jeyaganth; Moamen Amin; Wassim Kassouf
Journal:  World J Urol       Date:  2009-10-14       Impact factor: 4.226

9.  Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy.

Authors:  Barthold Ph Schrier; Maarten P Hollander; Bas W G van Rhijn; Lambertus A L M Kiemeney; J Alfred Witjes
Journal:  Eur Urol       Date:  2004-03       Impact factor: 20.096

10.  Peri-operative morbidity associated with radical cystectomy in a multicenter database of community and academic hospitals.

Authors:  Luke T Lavallée; David Schramm; Kelsey Witiuk; Ranjeeta Mallick; Dean Fergusson; Christopher Morash; Ilias Cagiannos; Rodney H Breau
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.